“If companies can compound earnings by even 17-18% or so, for an extended period of time, then you have a multibagger in your investment holdings. This is true of the last so many stocks that I have seen for the last 10-15 years or so. The critical thing is to remain invested and ride through the turbulence.”
"Companies like Bhel, which have the spare capacity, which have the technology, which have been more or less pre-qualified for many projects and orders are getting the true benefit of it. So, from a valuation perspective, from near-term prospects and also medium-term prospects, certainly there is a trading opportunity in Bhel and with the kind of momentum that is in the stock, it can easily rally by another 10-15% or so. But I would not like to invest in Bhel in the longer term."
"Paytm, Zomato, PolicyBazaar, Nykaa are entrepreneur driven companies and in India, you make a lot of money if you bet on the right entrepreneur, as we have seen with Reliance Industries, Asian Paints or Titan, for that matter, the Tata Group companies. These companies have all the right ingredients for a multibagger. If you remain patiently invested at some point of time, positive news flow will drive the stock prices higher."
"The next few quarters may certainly be very good for pharma companies. But these are no longer the secular growth stories which we have pursued back in the 2000 or 2010 era, when companies like Sun Pharma, Lupin, Dr. Reddy, Cipla were easily growing at 20% plus," says Dipan Mehta.
Investors in India are reportedly waiting to buy stocks after expecting a market correction. Dipan Mehta, Director of Elixir Equities, said 90% of people spoken to in the last two months were cautious, expecting a correction and the bulls have been waiting for an opportunity like this. In terms of sectors, Mehta believes there is a better chance of a decent return in inward-looking industries such as banking, capital goods, real estate, and hospitality, rather than export-oriented businesses.